<bill session="117" type="s" number="4341" updated="2023-03-08T20:12:35Z">
  <state datetime="2022-05-26">REFERRED</state>
  <status>
    <introduced datetime="2022-05-26"/>
  </status>
  <introduced datetime="2022-05-26"/>
  <titles>
    <title type="display">Advancing Affordable Medicines for Families Act</title>
    <title type="short" as="introduced">Advancing Affordable Medicines for Families Act</title>
    <title type="official" as="introduced">A bill to require the Government Accountability Office to issue a report on nonprofit pharmaceutical organizations.</title>
  </titles>
  <sponsor bioguide_id="R000608"/>
  <cosponsors>
    <cosponsor bioguide_id="R000615" joined="2022-05-26"/>
  </cosponsors>
  <actions>
    <action datetime="2022-05-26">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-05-26" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-08-27T19:38:22Z" status="Introduced in Senate">Advancing Affordable Medicines for Families Act

This bill requires the Government Accountability Office to report on the potential impact of nonprofit pharmaceutical organizations on the availability and cost of drugs as well as such organizations' potential to accelerate development of new drugs, generic drugs, new biological products, biosimilar products, cell-based therapies, and medical devices.</summary>
</bill>
